Christian Asbrand

Title: Christian Asbrand: Innovator in Immunology

Introduction

Christian Asbrand is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of immunology, particularly in the development of novel therapeutic drugs. With a total of 2 patents, his work focuses on addressing inflammatory and autoimmune diseases.

Latest Patents

Asbrand's latest patents include innovative polypeptides that target specific cytokines involved in inflammatory responses. The first patent describes polypeptides comprising immunoglobulin single variable domains that specifically bind to IL-6 and TNF-α. This novel drug aims to treat subjects suffering from rheumatoid arthritis and other inflammatory diseases. The second patent focuses on polypeptides that target TNF-α and IL-23, providing a new approach to drug development in immunology. Both patents also encompass nucleic acids, vectors, and compositions related to these polypeptides.

Career Highlights

Throughout his career, Christian Asbrand has worked with prominent companies in the pharmaceutical industry. He has been associated with Ablynx N.V. and Sanofi, where he contributed to the advancement of therapeutic solutions in immunology. His expertise and innovative approach have positioned him as a key figure in the development of new drugs.

Collaborations

Asbrand has collaborated with notable professionals in his field, including Heidi Rommelaere and Ann Brigé. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in drug therapy.

Conclusion

Christian Asbrand's contributions to immunology through his patents and career achievements highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in treating autoimmune diseases.